Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex

American Journal of Transplantation

Volumn 8, Issue 5, 2008, Pages 1025-1030

  Alexander, B D ^a   Petzold, E W ^a   Reller, L B ^a   Palmer, S M ^a   Davis, R D ^a   Woods, C W ^a   LiPuma, J J ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bacterial infection; Lung transplantation; Transplant infectious diseases; Transplant outcome

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; BETA LACTAM ANTIBIOTIC; COLISTIN; CORTICOSTEROID; CYCLOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBOSOME DNA; SULFONAMIDE; TACROLIMUS; TOBRAMYCIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA COMPLEX; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENETIC ANALYSIS; GRAFT SURVIVAL; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RECA GENE; REINFECTION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS;

EID: 42149146185     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02186.x     Document Type: Article

References (30)

1. Coenye T, Vandamme P, Govan JR, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 2001 39 : 3427 3436.
2. LiPuma JJ. Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 2003 24 : 681 692.
3. Vandamme P, Holmes B, Vancanneyt M et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 1997 47 : 1188 1200.
4. Vandamme P, Henry D, Coenye T et al. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol 2002 33 : 143 149.
5. Isles A, Maclusky I, Corey M et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984 104 : 206 210.
6. Tablan OC, Martone WJ, Doershuk CF et al. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest 1987 91 : 527 532.
7. Courtney JM, Dunbar KE, McDowell A et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004 3 : 93 98.
8. Reik R, Spilker T, LiPuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005 43 : 2926 2928.
9. LiPuma JJ, Spilker T, Gill LH, Campbell PW III., Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001 164 : 92 96.
10. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002 8 : 181 187.
11. Agodi A, Mahenthiralingam E, Barchitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: Prevalence, epidemiology, and genomovar status. J Clin Microbiol 2001 39 : 2891 2896.
12. LiPuma JJ. Burkholderia cepacia. Management issues and new insights. Clin Chest Med 2000 19 : 473 486.
13. Woods CW, Bressler AM, LiPuma JJ et al. Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. Clin Infect Dis 2004 38 : 1243 1250.
14. Steinbach S, Sun L, Jiang RZ et al. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994 331 : 981 987.
15. Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997 155 : 1699 1704.
16. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993 103 : 466 471.
17. Chaparro C, Maurer J, Gutierrez C et al. Infection with Burkholderia cepacia in cystic fibrosis: Outcome following lung transplantation. Am J Respir Crit Care Med 2001 163 : 43 48.
18. Kanj SS, Tapson V, Davis RD, Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997 112 : 924 930.
19. Egan JJ, Chadwick P, Lowe L, Woodcock AA. The potential of nosocomial transmission of Pseudomonas cepacia exists at cardiopulmonary transplant centers. Chest 1994 105 : 1630 1631.
20. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994 149 : 1601 1607.
21. De Soyza A, McDowell A, Archer L et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001 358 : 1780 1781.
22. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001 164 : 2102 2106.
23. Mahenthiralingam E, Vandamme P, Campbell ME et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: Virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 2001 33 : 1469 1475.
24. Hadjiliadis D, Howell DN, Davis RD et al. Anastomotic infections in lung transplant recipients. Ann Transplant 2000 5 : 13 19.
25. Palmer SM, Perfect JR, Howell DN et al. Candidal anastomotic infection in lung transplant recipients: Successful treatment with a combination of systemic and inhaled antifungal agents. J Heart Lung Transplant 1998 17 : 1029 1033.
26. LiPuma JJ, Dulaney BJ, McMenamin JD et al. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 1999 37 : 3167 3170.
27. Mahenthiralingam E, Bischof J, Byrne SK et al. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000 38 : 3165 3173.
28. Coenye T, Spilker T, Martin A, LiPuma JJ. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol 2002 40 : 3300 3307.
29. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002 57 : 142 145.
30. Orens JB, Estenne M, Arcasoy S et al. International guidelines for the selection of lung transplant candidates: 2006 update-A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 25 : 745 755.